Home/Filings/4/0001104659-21-089398
4//SEC Filing

Pirozzi Gianluca 4

Accession 0001104659-21-089398

CIK 0001504167other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:07 PM ET

Size

5.9 KB

Accession

0001104659-21-089398

Insider Transaction Report

Form 4
Period: 2021-07-01
Transactions
  • Award

    Stock Option (right to buy)

    2021-07-01+47,62347,623 total
    Exercise: $1.18Exp: 2031-07-01Common Stock, par value $0.001 per share (47,623 underlying)
Footnotes (2)
  • [F1]The option grant was approved by the compensation committee of the board of directors of Timber Pharmaceuticals, Inc. (the "Company") on April 21, 2021, subject to stockholder approval of an amendment to the Company's 2020 Omnibus Equity Incentive Plan (the "Amendment"). The Company's stockholders approved the Amendment on July 1, 2021.
  • [F2]The option grant will vest in 24 equal monthly installments beginning on August 1, 2021.

Issuer

Timber Pharmaceuticals, Inc.

CIK 0001504167

Entity typeother

Related Parties

1
  • filerCIK 0001809894

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:07 PM ET
Size
5.9 KB